These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 5171066

  • 1. Levodopa in the treatment of Parkinsonism.
    Cotzias GC.
    JAMA; 1971 Dec 27; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract] [Full Text] [Related]

  • 2. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC, Tang L, Ginos JZ, Nicholson AR, Papavasiliou PS.
    Nature; 1971 Jun 25; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract] [Full Text] [Related]

  • 3. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS, Cotzias GC, Düby SE, Steck AJ, Fehling C, Bell MA.
    N Engl J Med; 1972 Jan 06; 286(1):8-14. PubMed ID: 4550085
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB, Reid JL, Vakil SD, Rao S, Petrie A, Pallis CA, Gawler J, Thomas PK, Hilson A.
    Br Med J; 1971 Sep 25; 3(5777):729-32. PubMed ID: 4938431
    [Abstract] [Full Text] [Related]

  • 6. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
    Hornykiewicz OD.
    Neurology; 1970 Dec 25; 20(12):1-5. PubMed ID: 5531292
    [No Abstract] [Full Text] [Related]

  • 7. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F, Constantinidis J, Eisenring JJ, Krassoievitch M, Yanniotis G, Tissot R.
    Clin Chim Acta; 1971 Jun 25; 33(1):111-5. PubMed ID: 5097993
    [No Abstract] [Full Text] [Related]

  • 8. Dopa-decarboxylase inhibitors.
    Lancet; 1973 May 05; 1(7810):979-80. PubMed ID: 4121597
    [No Abstract] [Full Text] [Related]

  • 9. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK.
    Acta Neurol Scand Suppl; 1972 May 05; 51():59-103. PubMed ID: 4576076
    [No Abstract] [Full Text] [Related]

  • 10. Levodopa and pressor amine sensitivity in parkinsonism.
    Reid JL, Calne DB, George CF, Vakil SD.
    Clin Pharmacol Ther; 1972 May 05; 13(3):400-6. PubMed ID: 5026378
    [No Abstract] [Full Text] [Related]

  • 11. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM, Wiener L.
    Neurology; 1974 May 05; 24(5):482-6. PubMed ID: 4857107
    [No Abstract] [Full Text] [Related]

  • 12. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL, Calne DB, George CF, Vakil SD.
    Clin Sci; 1972 Dec 05; 43(6):851-9. PubMed ID: 4646277
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
    Holmsen R, Kvan L, Presthus J, Thoresen GB.
    Acta Neurol Scand Suppl; 1972 Dec 05; 51():121-2. PubMed ID: 4514336
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR, Messiha FS, Hsu TH.
    Clin Pharmacol Ther; 1972 Dec 05; 13(4):584-94. PubMed ID: 5042372
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.
    Dietrichson P.
    Acta Neurol Scand Suppl; 1972 Dec 05; 51():111-3. PubMed ID: 4514333
    [No Abstract] [Full Text] [Related]

  • 16. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M.
    Sci Basis Med Annu Rev; 1970 Dec 05; ():276-91. PubMed ID: 4319923
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
    Barbeau A, Gillo-Joffroy L, Mars H, Arsenault A.
    Rev Can Biol; 1972 Dec 05; 31():Suppl:169-74. PubMed ID: 5052323
    [No Abstract] [Full Text] [Related]

  • 18. [Pathogenesis and treatment of manganese induced Parkinsonism].
    Ryzhkova MN, Tarasova LA.
    Gig Tr Prof Zabol; 1975 Nov 05; (11):31-4. PubMed ID: 1205189
    [No Abstract] [Full Text] [Related]

  • 19. Similarities between neurologic effects of L-dopa and of apomorphine.
    Cotzias GC, Papavasiliou PS, Fehling C, Kaufman B, Mena I.
    N Engl J Med; 1970 Jan 01; 282(1):31-3. PubMed ID: 4901383
    [No Abstract] [Full Text] [Related]

  • 20. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
    Calne DB, Petrie A, Rao S, Reid JL, Vakil SD.
    Br J Pharmacol; 1972 Jan 01; 44(1):162-4. PubMed ID: 5015036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.